Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

PubWeight™: 26.76‹?› | Rank: Top 0.01% | All-Time Top 10000

🔗 View Article (PMC 4340604)

Published in Lancet on December 18, 2014

Authors

GBD 2013 Mortality and Causes of Death Collaborators

Associated clinical trials:

Sub-dissociative Intranasal Ketamine for Pediatric Sickle Cell Pain Crises | NCT02573714

Prevention of Tuberculosis in Prisons | NCT03028129

Safe Motherhood Promotion and Newborn Survival (SMPNS) | NCT03032276

Integrated Treatment of Hepatitis C Virus Infection (INTRO-HCV) | NCT03155906

Toripalimab Combined With Gemcitabine/5--fluoropyrimidine for Advanced Cholangiocarcinoma | NCT03982680

Prevalence of Fetal Congenital Anomalies Among Pregnant Women Attending University Hospital | NCT04174235

Dose Response of Eccentric Exercise on Glycemic Control in Type II Diabetes Mellitus | NCT04790526

Articles citing this

(truncated to the top 100)

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 14.88

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature (2015) 7.02

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

The Global Burden of Cancer 2013. JAMA Oncol (2015) 5.93

The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet (2016) 5.51

Guideline Adherence and Outcomes in Severe Adult Traumatic Brain Injury for the CHIRAG (Collaborative Head Injury and Guidelines) Study. World Neurosurg (2016) 3.54

Mapping Plasmodium falciparum Mortality in Africa between 1990 and 2015. N Engl J Med (2016) 3.52

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (2016) 3.31

Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group. Lancet (2015) 3.09

Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (2016) 2.88

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76

Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (2016) 2.42

Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. Lancet (2016) 2.35

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2013. Cancer Res Treat (2016) 2.31

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (2016) 2.25

Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Burden of Disease 2013 Study. JAMA Pediatr (2016) 2.19

Changes in health in England, with analysis by English regions and areas of deprivation, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 2.15

Association between quantity and duration of snowfall and risk of myocardial infarction. CMAJ (2017) 2.04

The global burden of injury: incidence, mortality, disability-adjusted life years and time trends from the Global Burden of Disease study 2013. Inj Prev (2015) 1.96

The epidemiology of cardiovascular disease in the UK 2014. Heart (2015) 1.93

Blue Marble Health Redux: Neglected Tropical Diseases and Human Development in the Group of 20 (G20) Nations and Nigeria. PLoS Negl Trop Dis (2015) 1.73

Public health and international drug policy. Lancet (2016) 1.71

Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med (2015) 1.70

Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation (2016) 1.69

The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis (2016) 1.62

Causes of child death: comparison of MCEE and GBD 2013 estimates. Lancet (2015) 1.61

Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet (2016) 1.60

Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51

The role of inflammation in suicidal behaviour. Acta Psychiatr Scand (2015) 1.47

Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol (2016) 1.46

A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int (2015) 1.46

Diagnosis of Bacterial Bloodstream Infections: A 16S Metagenomics Approach. PLoS Negl Trop Dis (2016) 1.46

Research Investments in Global Health: A Systematic Analysis of UK Infectious Disease Research Funding and Global Health Metrics, 1997-2013. EBioMedicine (2015) 1.43

Health information priorities for more effective implementation and monitoring of non-communicable disease programs in low- and middle-income countries: lessons from the Pacific. BMC Med (2015) 1.43

The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care (2016) 1.43

Identification of more objective biomarkers for Blood-Stasis syndrome diagnosis. BMC Complement Altern Med (2016) 1.42

Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses. PLoS Med (2016) 1.40

Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis. Lancet Oncol (2016) 1.40

The total artificial heart. J Thorac Dis (2015) 1.39

World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology (2015) 1.38

Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (2016) 1.38

Donor Financing of Global Mental Health, 1995-2015: An Assessment of Trends, Channels, and Alignment with the Disease Burden. PLoS One (2017) 1.38

Texas and Its Measles Epidemics. PLoS Med (2016) 1.38

H-NS, Its Family Members and Their Regulation of Virulence Genes in Shigella Species. Genes (Basel) (2016) 1.38

Air Pollution in China: Mapping of Concentrations and Sources. PLoS One (2015) 1.34

Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (2016) 1.31

Health in the sustainable development goals: ready for a paradigm shift? Global Health (2015) 1.27

How does living with HIV impact on women's mental health? Voices from a global survey. J Int AIDS Soc (2015) 1.25

Mortality from cardiovascular diseases in sub-Saharan Africa, 1990-2013: a systematic analysis of data from the Global Burden of Disease Study 2013. Cardiovasc J Afr (2015) 1.23

Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response. Clin Infect Dis (2015) 1.22

Training and Capacity Building in LMIC for Research in Heart and Lung Diseases: The NHLBI-UnitedHealth Global Health Centers of Excellence Program. Glob Heart (2016) 1.17

Progress in Medicine: Experts Take Stock. PLoS Med (2015) 1.16

Maternal and newborn outcomes in Pakistan compared to other low and middle income countries in the Global Network's Maternal Newborn Health Registry: an active, community-based, pregnancy surveillance mechanism. Reprod Health (2015) 1.10

Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules. Pediatrics (2016) 1.07

Colorectal cancer. Nat Rev Dis Prim (2015) 1.07

Causes of child death: comparison of MCEE and GBD 2013 estimates - Authors' reply. Lancet (2015) 1.05

Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study. Neuroepidemiology (2015) 1.04

Cardiovascular screening to reduce the burden from cardiovascular disease: microsimulation study to quantify policy options. BMJ (2016) 1.04

Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ (2017) 1.02

Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years: Results from the Global Burden of Disease Study 2013. Neuroepidemiology (2015) 1.02

Application of a Modified Garbage Code Algorithm to Estimate Cause-Specific Mortality and Years of Life Lost in Korea. J Korean Med Sci (2016) 1.02

Progress and promise in understanding the genetic basis of common diseases. Proc Biol Sci (2015) 1.02

Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis. Clin Infect Dis (2016) 1.01

30-Day In-hospital Trauma Mortality in Four Urban University Hospitals Using an Indian Trauma Registry. World J Surg (2016) 1.00

Precision Medicine: Clarity for the Complexity of Dementia. Am J Pathol (2015) 0.97

Better health intelligence: a new era for civil registration and vital statistics? BMC Med (2015) 0.95

Trends in mortality due to diabetes in Brazil, 1996-2011. Diabetol Metab Syndr (2015) 0.95

Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis. PLoS Med (2016) 0.94

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014. Cancer Res Treat (2017) 0.93

Epidemiology and aetiology of heart failure. Nat Rev Cardiol (2016) 0.93

Risk factors for severe neonatal hyperbilirubinemia in low and middle-income countries: a systematic review and meta-analysis. PLoS One (2015) 0.93

Prevalence of Pragmatically Defined High CV Risk and its Correlates in LMIC: A Report From 10 LMIC Areas in Africa, Asia, and South America. Glob Heart (2016) 0.92

Dealing with Danger in the CNS: The Response of the Immune System to Injury. Neuron (2015) 0.91

Chronic kidney disease in low- and middle-income countries. Nephrol Dial Transplant (2016) 0.91

Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells. Oncotarget (2016) 0.90

Primary prevention and risk factor reduction in coronary heart disease mortality among working aged men and women in eastern Finland over 40 years: population based observational study. BMJ (2016) 0.90

Reassortment in segmented RNA viruses: mechanisms and outcomes. Nat Rev Microbiol (2016) 0.90

Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies. BMJ (2016) 0.90

Transformative Innovations in Reproductive, Maternal, Newborn, and Child Health over the Next 20 Years. PLoS Med (2016) 0.89

A Birth Cohort Study of Maternal and Infant Serum PCB-153 and DDE Concentrations and Responses to Infant Tuberculosis Vaccination. Environ Health Perspect (2015) 0.89

Mapping pneumonia research: A systematic analysis of UK investments and published outputs 1997-2013. EBioMedicine (2015) 0.89

Global health metrics needs collaboration and competition. Lancet (2014) 0.89

Noncommunicable Lung Disease in Sub-Saharan Africa. A Community-based Cross-Sectional Study of Adults in Urban Malawi. Am J Respir Crit Care Med (2016) 0.89

Why and when citizens call for emergency help: an observational study of 211,193 medical emergency calls. Scand J Trauma Resusc Emerg Med (2015) 0.88

Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol (2015) 0.88

Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med (2016) 0.88

Global disease burden due to antibiotic resistance - state of the evidence. J Glob Health (2016) 0.88

Longitudinal multiple sclerosis lesion segmentation: resource & challenge. Neuroimage (2017) 0.88

Electronic Quality of Life Assessment Using Computer-Adaptive Testing. J Med Internet Res (2016) 0.88

Disparities in cardiovascular research output and citations from 52 African countries: a time-trend, bibliometric analysis (1999-2008). J Am Heart Assoc (2015) 0.88

Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective studies. BMC Med (2016) 0.88

Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program. Addiction (2015) 0.87

Difficulties in estimating the human burden of canine rabies. Acta Trop (2015) 0.87

Efficacy of a Russian-backbone live attenuated influenza vaccine among children in Senegal: a randomised, double-blind, placebo-controlled trial. Lancet Glob Health (2016) 0.87

The Impacts of Dietary Change on Greenhouse Gas Emissions, Land Use, Water Use, and Health: A Systematic Review. PLoS One (2016) 0.87

Power in global health agenda-setting: the role of private funding Comment on "Knowledge, moral claims and the exercise of power in global health". Int J Health Policy Manag (2015) 0.87

Predictive biomarkers in precision medicine and drug development against lung cancer. Chin J Cancer (2015) 0.87

Causes of Death Data in the Global Burden of Disease Estimates for Ischemic and Hemorrhagic Stroke. Neuroepidemiology (2015) 0.87

From Data to Action: Neuroepidemiology Informs Implementation Research for Global Stroke Prevention and Treatment. Neuroepidemiology (2015) 0.87

Articles cited by this

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 50.94

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2014) 22.33

Global health 2035: a world converging within a generation. Lancet (2013) 16.85

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet (2009) 15.31

Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet (2013) 14.06

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet (2010) 13.86

Deciphering death: a commentary on Gompertz (1825) 'On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies'. Philos Trans R Soc Lond B Biol Sci (2015) 12.50

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43

Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2014) 9.68

Global burden of childhood pneumonia and diarrhoea. Lancet (2013) 9.28

Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2014) 9.13

GBD 2010: design, definitions, and metrics. Lancet (2012) 8.64

Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet (2012) 8.22

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet (2005) 7.99

A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet (2013) 7.77

Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet (2011) 7.71

Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2013) 7.70

Global burden of disease in young people aged 10-24 years: a systematic analysis. Lancet (2011) 7.63

Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 7.62

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med (2003) 7.39

Global patterns of mortality in young people: a systematic analysis of population health data. Lancet (2009) 7.05

U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med (2013) 6.60

Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA (2014) 6.42

UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11

Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet (2011) 5.43

Increased educational attainment and its effect on child mortality in 175 countries between 1970 and 2009: a systematic analysis. Lancet (2010) 5.36

Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet (2009) 4.81

The experimental transmission of human intestinal protozoan parasites. II. Giardia lamblia cysts given in capsules. Am J Hyg (1954) 4.65

The global distribution of fatal pesticide self-poisoning: systematic review. BMC Public Health (2007) 4.65

Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants. Lancet (1997) 4.32

Good Health at Low Cost 25 years on: lessons for the future of health systems strengthening. Lancet (2013) 4.03

Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial. Lancet (2005) 3.60

The Pneumonia Etiology Research for Child Health Project: a 21st century childhood pneumonia etiology study. Clin Infect Dis (2012) 3.40

Modeling causes of death: an integrated approach using CODEm. Popul Health Metr (2012) 3.12

A heuristic approach to the formulas for population attributable fraction. J Epidemiol Community Health (2001) 3.07

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J (2002) 2.94

Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial. Pediatr Infect Dis J (2009) 2.73

The burden of HIV: insights from the Global Burden of Disease Study 2010. AIDS (2013) 2.66

What can we conclude from death registration? Improved methods for evaluating completeness. PLoS Med (2010) 2.61

World mortality 1950-2000: divergence replaces convergence from the late 1980s. Bull World Health Organ (2005) 2.60

Discrepancies between clinical and autopsy diagnosis and the value of post mortem histology; a meta-analysis and review. Histopathology (2005) 2.52

Tackling human fungal infections. Science (2012) 2.49

Experimental human infections with Giardia lamblia. J Infect Dis (1987) 2.42

Using verbal autopsy to measure causes of death: the comparative performance of existing methods. BMC Med (2014) 2.39

Measuring adult mortality using sibling survival: a new analytical method and new results for 44 countries, 1974-2006. PLoS Med (2010) 2.32

Understanding the coronary heart disease versus total cardiovascular mortality paradox: a method to enhance the comparability of cardiovascular death statistics in the United States. Circulation (2006) 2.20

On the scale of global demographic convergence, 1950-2000. Popul Dev Rev (2001) 2.07

Improving responsiveness of health systems to non-communicable diseases. Lancet (2013) 2.06

Diagnostic errors in three medical eras: a necropsy study. Lancet (2000) 2.02

Contagious acute gastrointestinal infections. N Engl J Med (2004) 1.96

Ending preventable maternal deaths: the time is now. Lancet Glob Health (2013) 1.95

Developing a comprehensive time series of GDP per capita for 210 countries from 1950 to 2015. Popul Health Metr (2012) 1.95

Chikungunya epidemic: an Indian perspective. Natl Med J India (2007) 1.90

Evaluating causes of death and morbidity in Iran, global burden of diseases, injuries, and risk factors study 2010. Arch Iran Med (2014) 1.86

An integrated approach to cause-of-death analysis: cause-deleted life tables and decompositions of life expectancy. Demogr Res (2008) 1.74

Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b. Pediatr Infect Dis J (1999) 1.73

Effectiveness of Haemophilus influenzae type B conjugate vaccine on prevention of pneumonia and meningitis in Bangladeshi children: a case-control study. Pediatr Infect Dis J (2007) 1.70

The Global Enteric Multicenter Study (GEMS): impetus, rationale, and genesis. Clin Infect Dis (2012) 1.66

Mortality traps and the dynamics of health transitions. Proc Natl Acad Sci U S A (2007) 1.63

Dengue fever in the Indian Subcontinent: an overview. J Infect Dev Ctries (2011) 1.63

Statistical methods in the Global Enteric Multicenter Study (GEMS). Clin Infect Dis (2012) 1.59

Use of vaccines as probes to define disease burden. Lancet (2014) 1.56

Alcohol increases circulatory disease mortality in Russia: acute and chronic effects or misattribution of cause? Int J Epidemiol (2010) 1.45

Improving the public health utility of global cardiovascular mortality data: the rise of ischemic heart disease. Popul Health Metr (2011) 1.43

Reconstructing Past Populations With Uncertainty From Fragmentary Data. J Am Stat Assoc (2013) 1.33

Health transition in Iran toward chronic diseases based on results of Global Burden of Disease 2010. Arch Iran Med (2014) 1.31

Population health and burden of disease profile of Iran among 20 countries in the region: from Afghanistan to Qatar and Lebanon. Arch Iran Med (2014) 1.29

Giardiasis: a review on assemblage distribution and epidemiology in India. Indian J Gastroenterol (2012) 1.22

Contribution of vaccines to our understanding of pneumococcal disease. Philos Trans R Soc Lond B Biol Sci (2011) 1.21

Health response system for Syria: beyond official narrative. Lancet (2014) 1.17

World health inequality: convergence, divergence, and development. Soc Sci Med (2010) 1.16

Integrating mental health into primary care for displaced populations: the experience of Mindanao, Philippines. Confl Health (2011) 1.16

The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines. Vaccine (2008) 1.14

[Burden of disease, injuries, risk factors and challenges for the health system in Mexico]. Salud Publica Mex (2013) 1.11

Incidence, case fatality and genotypes causing Clostridium difficile infections, Finland, 2008. Clin Microbiol Infect (2010) 1.07

Swine flu is back again: a review. Pak J Biol Sci (2012) 1.05

Chikungunya epidemic: global and Indian scenario. J Commun Dis (2007) 1.05

Haemophilus influenzae type b disease among children in rural Mozambique: impact of vaccine introduction. J Pediatr (2013) 1.01

Maternal deaths in Norway 2005-2009. Tidsskr Nor Laegeforen (2014) 1.00